Home page of The Cochrane Collaboration

Cochrane Prostatic Diseases and Urologic Cancers Group

Our reviews

Other Languages

view stage (what is this?):(stage filter not available for subtopic view)

Full list:

5-alpha-reductase inhibitors for benign prostatic hyperplasia

5-alpha-reductase inhibitors for prostate cancer prevention

Serenoa repens for benign prostatic hyperplasia

Active surveillance versus surgical intervention for small renal masses

Adjuvant chemotherapy for invasive bladder cancer (individual patient data)

Adjuvant radiotherapy following radical prostatectomy for prostate cancer

Adjuvant treatment for stage I nonseminomatous testicular cancer

Alfuzosin for benign prostatic hyperplasia

Allopurinol for chronic prostatitis

Altered radiation fractionation schedules for the treatment of prostate cancer

Analgesia for transrectal ultrasonographic guided prostate biopsies

Antibiotic prophylaxis for transrectal prostate biopsy

Antimicrobial therapy for chronic bacterial prostatitis

Apomorphine for the treatment of erectile dysfunction

Assessing the effects of three urinary diversion techniques for quality of life differences in bladder cancer patients

Beta-sitosterols for benign prostatic hyperplasia

Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction

Bisphosphonates for advanced prostate cancer

Bisphosphonates in early prostate cancer

Chemoprevention agents (biologic, botanical, and synthetic) for prostate cancer

Chemotherapy for hormone-refractory prostate cancer

Circumcision for the prevention of prostate cancer

Cryotherapy for localised prostate cancer

Dapoxetine for the treatment of premature ejaculation

Denosumab for men with prostate cancer

Diagnostic accuracy of image guided biopsies in patients with small and indeterminate renal masses

Dose-escalated radiotherapy for localised prostate cancer

Doxazosin for benign prostatic obstruction

Dynamic sentinel lymph-node biopsy versus traditional open inguinal lymphadenectomy for penile cancer

Early versus deferred androgen suppression in the treatment of advanced prostatic cancer

Effects of the duration of androgen deprivation therapy for localized or locally advanced prostate cancer in patients treated with radiotherapy

Endothelin inhibitors for advanced prostate cancer

Exercise for the treatment of benign prostatic hyperplasia

Finasteride for benign prostatic hyperplasia

First-line docetaxel chemotherapy for castrate-resistant prostate cancer

Gemcitabine for unresectable, locally advanced or metastatic bladder cancer

Ginseng versus placebo for erectile dysfunction

GnRH antagonists versus GnRH agonists for the treatment of prostate cancer

High dose versus low dose intravesical interferon-alpha 2b for the treatment of carcinoma in situ of the bladder

High intensity focused ultrasound for prostate cancer

Immunotherapy for advanced renal cell cancer

Intermittent versus continuous androgen suppression for prostatic cancer

Interventions for Peyronie's disease

Interventions for chronic abacterial prostatitis

Intravesical Bacillus Calmette-Guérin in Ta and T1 bladder cancer

Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer

Intravesical doxorubicin versus epirubicin for superficial bladder cancer

Intravesical gemcitabine for non-muscle invasive bladder cancer

Laparoscopic radical cystectomy for bladder cancer

Laparoscopic versus open prostatectomy for the treatment of localised prostate cancer

Laser prostatectomy for benign prostatic obstruction

Low-dose rate brachytherapy for men with localized prostate cancer

Lycopene for the prevention of prostate cancer

Maximal androgen blockade for advanced prostate cancer

Microwave thermotherapy for benign prostatic hyperplasia

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia

Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer

Neo-adjuvant chemotherapy for invasive bladder cancer

Non-steroidal antiandrogens compared to LHRH agonists or surgical castration therapy for advanced prostate cancer

Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy

Pelvic lymph node dissection for invasive bladder cancer

Penile rehabilitation for post-prostatectomy erectile dysfunction

Perioperative enhanced recovery programmes for renal cancer patients

Perioperative nutrition for the treatment of bladder cancer by radical cystectomy

Pharmacotherapy for premature ejaculation

Plasmakinetic resection versus transurethral resection of the prostate for benign prostatic hyperplasia

Pre-surgical finasteride to reduce perioperative bleeding and other complications following transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH)

Pregabalin for chronic prostatitis

Provenge (sipuleucel-T) for prostate cancer

Psychosocial interventions for erectile dysfunction

Psychosocial interventions for men with prostate cancer

Psychosocial interventions for premature ejaculation

Pygeum africanum for benign prostatic hyperplasia

Radical prostatectomy versus watchful waiting for prostate cancer

Retropubic versus perineal radical prostatectomy for the treatment of localised prostate cancer

Robotic versus open radical cystectomy

Screening for prostate cancer

Screening for testicular cancer

Second-line, post-docetaxel therapy for advanced, androgen deprivation-refractory prostate cancer

Silodosin for benign prostatic hyperplasia

Surgery versus radiotherapy for muscle invasive bladder cancer

Surgical management for penile cancer

Surgical management for upper urinary tract transitional cell carcinoma

Surgical management of localised renal cell carcinoma

Targeted therapy for advanced renal cell carcinoma

Transperitoneal versus retroperitoneal radical laparoscopic nephrectomy for renal cell cancer

By subtopic:

Benign Prostatic Hyperplasia/Obstruction (Hypertrophy, Prostatic Hyperplasia) (14)

Treatment of Benign Prostatic Hyperplasia (14)

Minimally Invasive Procedures (4)

Laser prostatectomy (3)

Endoscopic laser ablation of the prostate (ELAP) (1)

Laser prostatectomy for benign prostatic obstruction

Hybrid lasers (1)

Laser prostatectomy for benign prostatic obstruction

Transuretal ultrasound-guided (TULIP) (0)

Visual laser ablation of the prostate (VLAP) (1)

Laser prostatectomy for benign prostatic obstruction

Microwave/Thermo Therapies (1)

Transurethral microwave therapy (TUMT) (1)

Microwave thermotherapy for benign prostatic hyperplasia

Transrectal High-Intensity Focused Ultrasound Therapy (0)

Transrectal Needle Ablation of the Prostate (0)

Pharmacologic/Medical Therapies (8)

Alpha-blockers/Alpha-1 adrenoceptors/Alpha antagonists/5-alpha reductase inhibitors (4)

Alfuzosin for benign prostatic hyperplasia (protocol stage)

Doxazosin for benign prostatic obstruction (protocol stage)

Finasteride (1)

Pre-surgical finasteride to reduce perioperative bleeding and other complications following transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH) (protocol stage)

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia

Androgen Suppression (1)

5 Alpha-reductase inhibitors (1)

Finasteride for benign prostatic hyperplasia

Antiandrogens (0)

Combined androgen suppression and alpha-blockade (0)

Gonadotropin-releasing hormone agonists (0)

Phytotherapies/Plant extracts (3)

Serenoa repens for benign prostatic hyperplasia

Pygeum africanum for benign prostatic hyperplasia

Beta-sitosterols for benign prostatic hyperplasia

Transurethral resection of the prostate (TURP) (2)

Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction (protocol stage)

Plasmakinetic resection versus transurethral resection of the prostate for benign prostatic hyperplasia (protocol stage)

Transvesical prostatectomy (TVP) (0)

Bladder Cancer (Malignancy, Neoplasia): [Superficial, muscle-invasive, metastatic} (13)

Diet/nutrition (1)

Perioperative nutrition for the treatment of bladder cancer by radical cystectomy (protocol stage)

Treatment of Metastatic Bladder Cancer (1)

Chemotherapy (To include combination programs) (1)

Gemcitabine (1)

Gemcitabine for unresectable, locally advanced or metastatic bladder cancer

Methotrexate (0)

Mitomycin C (0)

Vinblastine (0)

Treatment of Muscle-invasive Bladder Cancer (4)

Adjuvant therapy (1)

Adjuvant chemotherapy for invasive bladder cancer (individual patient data)

Radiotherapy (2)

Surgery versus radiotherapy for muscle invasive bladder cancer

Neo-adjuvant chemotherapy for invasive bladder cancer

Surgery versus radiotherapy for muscle invasive bladder cancer

Treatment of Superficial Bladder Cancer (7)

Bacillus Calmette Guerin (BCG) (3)

Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer

Intravesical Bacillus Calmette-Guérin in Ta and T1 bladder cancer

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer

Chemotherapy (2)

Intravesical gemcitabine for non-muscle invasive bladder cancer

High dose versus low dose intravesical interferon-alpha 2b for the treatment of carcinoma in situ of the bladder (protocol stage)

Doxorubicin (1)

Intravesical doxorubicin versus epirubicin for superficial bladder cancer (protocol stage)

Laser Nd: YAG (0)

Mitomycin C (0)

Photodynamic Therapy (Hematoporphyrin Derivative (HpD) (0)

Laparoscopic radical cystectomy for bladder cancer (protocol stage)

Erectile Dysfunction (2)

Treatment of Erectile Dysfunction (2)

Pharmacologic/Medical Therapies (1)

Oral Drug Therapy (1)

Apomorphine (1)

Apomorphine for the treatment of erectile dysfunction (protocol stage)

Phentolamine (0)

Transdermal/Topical Applications (0)

Vasoactive Drug Injection Therapy (0)

Phytotherapies (0)

Psychosocial interventions (1)

Psychosocial interventions for erectile dysfunction

Miscellaneous (1)

Interventions for Peyronie's disease (protocol stage)

Other Urologic Cancers (Testicular, Penile, Urethral) (2)

Testicular Cancer (Malignancy, Neoplasia): [nonseminoma, seminoma, disseminated testicular] (1)

Screening for testicular cancer

Treatment of Disseminated Testicular Cancer (0)

Treatment of Nonseminoma (0)

Treatment of Seminoma (0)

Urethral Cancer (Malignancy, Neoplasia) (1)

Treatment of Urethral Cancer (1)

Surgery (Urinary diversion) (1)

Surgical management for upper urinary tract transitional cell carcinoma

Premature ejaculation (PE) (1)

Psychosocial interventions for premature ejaculation

Prostate Cancer (Malignancy, Neoplasm) (23)

Cryotherapy (1)

Cryotherapy for localised prostate cancer

Immunotherapy (0)

Prevention of Prostate Cancer (2)

Antioxidants (1)

Lycopene for the prevention of prostate cancer

Fat modified (0)

Pharmacologic/Medical (1)

5-alpha-reductase inhibitors (1)

5-alpha-reductase inhibitors for prostate cancer prevention

Finasteride (0)

Radical prostatectomy (RP) (2)

Radical prostatectomy versus watchful waiting for prostate cancer

Laparoscopic versus open prostatectomy for the treatment of localised prostate cancer (protocol stage)

Rehabilitation/Management of Prostate Cancer (17)

Psychosocial interventions for men with prostate cancer (protocol stage)

Second-line, post-docetaxel therapy for advanced, androgen deprivation-refractory prostate cancer (protocol stage)

First-line docetaxel chemotherapy for castrate-resistant prostate cancer (protocol stage)

Intermittent versus continuous androgen suppression for prostatic cancer

Adjuvant radiotherapy following radical prostatectomy for prostate cancer

Endothelin inhibitors for advanced prostate cancer (protocol stage)

Non-steroidal antiandrogens compared to LHRH agonists or surgical castration therapy for advanced prostate cancer (protocol stage)

Low-dose rate brachytherapy for men with localized prostate cancer

Antibiotic prophylaxis for transrectal prostate biopsy

Bisphosphonates in early prostate cancer (protocol stage)

Early versus deferred androgen suppression in the treatment of advanced prostatic cancer

Effects of the duration of androgen deprivation therapy for localized or locally advanced prostate cancer in patients treated with radiotherapy (protocol stage)

Maximal androgen blockade for advanced prostate cancer

Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy

Bisphosphonates for advanced prostate cancer

Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer

Chemotherapy for hormone-refractory prostate cancer

Screening for Prostate Cancer (1)

Screening for prostate cancer

Renal Cancer (Malignancy, Neoplasia): Renal pelvis and ureteral tumors, renal cell carcinoma (4)

Treatment of Renal Cell Carcinoma (4)

Immunotherapy (2)

Active-nonspecific (1)

Targeted therapy for advanced renal cell carcinoma

Active-specific (0)

Bacillus Calmette Guérin (BCG) (0)

Corynebacterium parvum (0)

Dimethyldioctadecylammonium bromide (DDA) (0)

Ethylchlorformate (0)

Interferons (0)

Interleukin-2 (1)

Immunotherapy for advanced renal cell cancer

Miscellaneous (0)

Radiation Therapy (0)

Transperitoneal versus retroperitoneal radical laparoscopic nephrectomy for renal cell cancer (protocol stage)

Surgical management of localised renal cell carcinoma

Treatment of Renal Pelvis and Ureteral Tumors (0)

New + Updated:

Search

AllTrials

top of this page disclaimer The Cochrane Library The Cochrane Collaboration Admin